Karnalyte Resources Inc. Announces 2018 Year End Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEM.....»»

Cannabis retailer making significant progress o.....»»

VANCOUVER, April 1, 2019 /PRNewswire/ - Entrée Resources Ltd. (TSX:ETG, NYSE:EGI, Company", or ", Entrée", )) has today filed its annual operational a.....»»

GAITHERSBURG, Md., April 01, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a cli.....»»

Development of Phase 3 product candidate VB-111 continues in ovarian can.....»»

VANCOUVER, March 25, 2019 /PRNewswire/ - Golden Queen Mining Co. Ltd. (TSX:GQM, OTCQX:GQMNF) (the "Company" or "Golden Queen") announces its financial results for the year ended December 31, 2018 at its 50%-owned Soleda.....»»

Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients initiated in December 2018 First tRNA synthetase partnership announced in March 2019 SAN DIEGO, March .....»»

RANCHO CORDOVA, Calif., March 25, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell pro.....»»

CORAL GABLES, Fla., March 18, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (NASDAQ:CPRX), a biopharmaceutical compa.....»»

Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update.....»»

Oraxol Phase III clinical trial in metastatic breast cancer fully enrolled Positive Phase III topline results of KX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD Annual Meeting A numb.....»»

Karnalyte Resources Inc. Announces 2018 Second Quarter Results and Provides Update on Potash and Nitrogen Projects Canada NewsWire SASKATOON, Aug. 9, 2018 /NOT FOR DISTRIBU.....»»

Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update.....»»

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ SASKATOON, Nov. 14, 2018 /CNW/ - Karnal.....»»

JERUSALEM, Feb. 27, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces financial results for the fourth quarter and year ended December 31.....»»

Topline interim results from Phase 3 clinical trial RESOLVE-IT expected by the end of May 2020 Cash position of €277MM as of December 31, 2019 (vs €207MM as of December 31, 2018) Significant milestones achieved i.....»»

Oxford, Connecticut, March 31, 2020 (GLOBE NEWSWIRE) -- Nxt-ID, Inc. (NASDAQ: NXTD) (the "Company"), a provider of healthcare devices and services, announces results for the year and three months ended December 31, 2019. Financial Highlights and r.....»»

BioNTech Announces Full Year 2019 Financial Results and Corporate Update.....»»

CALGARY, Alberta, March 30, 2020 (GLOBE NEWSWIRE) -- Top Strike Resources Corp. d.b.a. "Vencanna Ventures" (the "Corporation" or "Vencanna") (CSE:VENI, OTCQB:TP.....»»

Altimmune Announces Financial Results for the Year Ended December 31, 2019 and Provides a Corporate Update.....»»